ReNeuron Group plc Stock
Your prediction
Pros and Cons of ReNeuron Group plc in the next few years
Pros
?
S********** s********
?
C******** o* t** e**********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of ReNeuron Group plc vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
ReNeuron Group plc | - | - | - | - | - | - | - |
Proteome Sciences | - | 0.000% | 0.000% | 11.111% | 6.667% | -39.850% | 300.000% |
Oxford BioMedica PLC | 12.200% | 46.032% | 64.286% | -20.346% | 50.820% | -69.333% | -52.208% |
Sareum Holdings plc | -4.170% | -7.383% | 119.048% | -80.000% | -55.122% | -76.000% | - |
Comments
News
Edison issues update on ReNeuron Group (RENE): H124 results reaffirm focus on CustomEX™
Edison issues update on ReNeuron Group (RENE): H124 results reaffirm focus on CustomEX™